Pacer Advisors Inc. Has $85.48 Million Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Pacer Advisors Inc. boosted its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 15,105.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 4,503,591 shares of the medical instruments supplier’s stock after acquiring an additional 4,473,972 shares during the quarter. Pacer Advisors Inc.’s holdings in DENTSPLY SIRONA were worth $85,478,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the stock. KBC Group NV grew its stake in shares of DENTSPLY SIRONA by 60.9% in the 4th quarter. KBC Group NV now owns 10,096 shares of the medical instruments supplier’s stock worth $192,000 after acquiring an additional 3,822 shares in the last quarter. Blue Trust Inc. boosted its holdings in DENTSPLY SIRONA by 10.9% during the fourth quarter. Blue Trust Inc. now owns 7,199 shares of the medical instruments supplier’s stock worth $137,000 after purchasing an additional 707 shares during the last quarter. Sound Income Strategies LLC grew its position in DENTSPLY SIRONA by 85.0% in the 4th quarter. Sound Income Strategies LLC now owns 242,064 shares of the medical instruments supplier’s stock worth $4,594,000 after purchasing an additional 111,199 shares in the last quarter. Avior Wealth Management LLC increased its stake in DENTSPLY SIRONA by 21.1% in the 4th quarter. Avior Wealth Management LLC now owns 34,400 shares of the medical instruments supplier’s stock valued at $653,000 after buying an additional 6,000 shares during the last quarter. Finally, Nisa Investment Advisors LLC lifted its position in shares of DENTSPLY SIRONA by 89.6% during the 4th quarter. Nisa Investment Advisors LLC now owns 54,397 shares of the medical instruments supplier’s stock worth $1,041,000 after buying an additional 25,705 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY opened at $19.53 on Monday. DENTSPLY SIRONA Inc. has a 1 year low of $17.21 and a 1 year high of $35.68. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The stock’s fifty day moving average price is $19.03 and its two-hundred day moving average price is $22.66.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The business had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. During the same quarter last year, the company earned $0.49 EPS. The firm’s revenue was up .4% compared to the same quarter last year. On average, research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, January 10th. Investors of record on Friday, December 27th were issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 3.28%. The ex-dividend date was Friday, December 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -30.92%.

Analysts Set New Price Targets

XRAY has been the subject of several recent analyst reports. Needham & Company LLC reduced their target price on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a report on Friday, October 25th. Jefferies Financial Group cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating and lowered their target price for the stock from $30.00 to $20.00 in a research note on Thursday. Leerink Partnrs lowered shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Mizuho started coverage on shares of DENTSPLY SIRONA in a report on Wednesday, December 4th. They set a “neutral” rating and a $21.00 price objective for the company. Finally, StockNews.com cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Tuesday, November 19th. Ten analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $26.67.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.